Vitrolife’s recent slowdown looks tied to people delaying fertility treatments, and a rebound could lift sales as policy clarity and clinic demand return. New products, more support for treatment costs in parts of Asia, and factory automation may help the business recover—while currency swings and legal and regulatory pressure remain key threats.Read more
Catalysts About Vitrolife Vitrolife provides products and services used in IVF clinics, including media, disposable devices, lab technologies and genetic testing. What are the underlying business or industry changes driving this perspective?Read more
Catalysts About Vitrolife Vitrolife develops and supplies advanced IVF media, consumables, technologies, and genetic testing solutions that support clinics across the full reproductive care workflow. What are the underlying business or industry changes driving this perspective?Read more
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.
